Home » Topics » Cancer, BioWorld Science

Cancer, BioWorld Science
RSS

New therapeutic options for cancer reported in recent patents

May 15, 2008

Oncolytics initiates enrollment in REO 012 clinical trial of Reolysin and cyclophosphamide

May 15, 2008

CY-503 evaluated in phase II stage IV malignant melanoma trial

May 15, 2008

Novelos presents positive results in ongoing phase II neoadjuvant breast cancer trial

May 14, 2008

Recent patent literature discloses new treatment options for cancer

May 14, 2008

Lodamin formulation allows oral administration of the antiangiogenic TNP-470

May 14, 2008

Novel oncolytic MP-529 shows activity in vivo

May 14, 2008

FDA grants orphan drug designation for palifosfamide in soft tissue sarcoma

May 13, 2008

BiPar expands phase II clinical trial programs for BSI-201 to include ovarian cancer

May 13, 2008

Dana-Farber Cancer Institute initiates phase I trial of EntreMed's ENMD-2076

May 13, 2008

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for April 10, 2026.
Hengrui discovers new Nav1.8 blockers
BioWorld Science
Researchers from Jiangsu Hengrui Pharmaceuticals Co. Ltd. and Shanghai Hengrui Pharmaceutical Co. Ltd. have patented new sodium channel protein type 10 subunit α...
Hematopoietic stem cell research points to leukemia’s early roots
BioWorld Science
Hematopoietic stem cell (HSC) research over the past century has shown that leukemia may be driven by an invisible hand of inflammation. The bone marrow and...
News in brief
BioWorld Asia
BioWorld Asia briefs for April 7, 2026
Korsana boosts Alzheimer’s work with reverse merger, $380M financing
BioWorld Science
Just over a month after emerging from stealth and disclosing a $150 million series A, Korsana Biosciences Inc. is making the leap to the public market via a...